Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
11/2010
11/25/2010US20100298308 Compositions and methods for bone formation and remodeling
11/25/2010US20100298278 Inhibitors of beta-secretase for the treatment of alzheimer's disease
11/25/2010US20100298200 Compounds and assays for controlling Wnt activity
11/25/2010US20100297684 Activatible dyes
11/25/2010US20100297077 Novel aryl potassium channel blockers and uses thereof
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010EP2252601A1 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/24/2010EP2252588A2 Process for preparing pyridone derivatives
11/24/2010CN101896811A Process of making 3-phenylimino-3H-phenothiazine or 3-phenylimino-3H-phenoxazine mediator
11/24/2010CN101896474A Method of making ketals and acetals
11/24/2010CN101896183A Bicyclic amides for enhancing glutamatergic synaptic responses
11/24/2010CN101891696A Poly-iodo acromatic compound and preparation method and application thereof
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010CA2487489C Mitotic kinesin inhibitors
11/18/2010WO2010130627A1 Polymerizable benzoxazine compounds with interfacial active or surface active properties
11/18/2010WO2010111626A3 Poly (adp-ribose) polymerase (parp) inhibitors
11/18/2010WO2010067078A3 3,6-disubstituted xanthylium salts as medicaments
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292229 Tryphostin-analogs for the treatment of cell proliferative diseases
11/18/2010DE102009003033A1 Polymerisierbare Benzoxazin-Verbindungen mit grenzflächenaktiven bzw. oberflächenaktiven Eigenschaften Polymerizable benzoxazine compounds with surfactants or surface-active properties
11/18/2010DE102009003032A1 Kationische Benzoxazin(co)polymere Benzoxazine cationic (co) polymers
11/17/2010CN101888989A Novel aryl potassium channel blockers and uses thereof
11/17/2010CN101888849A Sclerostin and the inhibition of wnt signaling and bone formation
11/16/2010US7834010 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/11/2010US20100286360 Polymer compound and polymer light emitting device using the same
11/11/2010US20100286138 Stable forms of N-(2,6-Dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide
11/11/2010US20100286125 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning
11/10/2010EP2247581A2 Cristallines, enantiomerically pure salt form of a betamimetic agent, and the use thereof as a medicament
11/09/2010US7829713 Therapeutic piperazines
11/09/2010US7829702 Racemic separation of 2,6-trans-dimethymorpholine
11/09/2010US7829560 such as N-(4-{[2-(4-Ethylpiperazin-1-yl)pyrimidin-4-yl]oxy}-1-naphthyl)-3-fluoro-5-piperidin-1-ylbenzamide, useful as antiproliferative agents or in treating arthritis, osteoarthritis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, psoriasis, autoimmune or inflammatory diseases
11/09/2010CA2594684C Morpholines as 5ht2c agonists
11/09/2010CA2434937C Phenyl derivatives
11/04/2010WO2010124521A1 Derivatives of rhein, preparation methods and uses thereof
11/04/2010WO2010124385A1 Processes for the preparation of rivaroxaban and intermediates thereof
11/04/2010US20100280243 Process for production of 4- (substituted phenyl) hexahydropyrido [2,1-c] [1,4] oxazin-6-one
11/04/2010US20100280242 Method of Preparing Cyclic Carbonates, Cyclic Carbamates, Cyclic Ureas, Cyclic Thiocarbonates, Cyclic Thiocarbamates, and Cyclic Dithiocarbonates
11/04/2010US20100280241 Spirooxazine radical derivatives and reversible isomerization reaction
11/04/2010US20100280024 Renin inhibitors
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100279997 Analgesic that binds filamin a
11/04/2010US20100279996 Novel analgesic that binds filamin a
11/04/2010CA2759828A1 Processes for the preparation of rivaroxaban and intermediates thereof
11/03/2010EP2245176A1 Agent for detecting seed viability and a detection method of seed viability using the agent
11/03/2010CN101878201A Fused indane compound
11/03/2010CN101875655A Aminobenzoic acid derivative as well as preparation method and application thereof
11/03/2010CN101875654A Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825113 2-oxy-benzoxazinone derivatives for the treatment of obesity
11/02/2010US7825105 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
11/02/2010CA2686545C Deuterated morpholinyl compounds
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123870A1 Heteroaryl compounds and uses thereof
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123047A1 Crystal of benzoxazinone compound
10/28/2010US20100274011 Method for the production of an amine
10/28/2010US20100274010 Method for producing an amine
10/28/2010US20100274009 Method for producing an amine
10/28/2010US20100274007 Process for preparing polymorphic forms of (s)-6-chloro-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2h-3,1-benzoxazin-2-one
10/28/2010US20100273790 Processes for the preparation of rivaroxaban and intermediates thereof
10/27/2010EP0975609B1 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
10/27/2010CN1878762B Morpholine derivatives as norepinephrine reuptake inhibitors
10/21/2010WO2010120889A1 Treatment of metabolic syndrome with cyclic amides
10/21/2010WO2010119906A1 Haloalkylsulfonanilide derivative
10/21/2010WO2010119275A1 Monomer, polymerization method, and polymer
10/21/2010US20100267948 Process for the preparation of an amine
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267715 Polymorph Form II of Tanaproget
10/21/2010US20100267713 4,4-disubstituted piperidines
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267695 Fused indane compound
10/21/2010US20100267669 Heterocyclic cetp inhibitors
10/21/2010CA2757729A1 Haloalkylsulfonanilide derivative
10/20/2010EP1780197B1 5-substituted-2-phenylamino benzamides as mek inhibitors
10/20/2010EP1613762B1 Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives
10/19/2010US7816527 Quinazoline-containing kits for labeling aldehyde or ketone moieties
10/19/2010US7816389 Organic compounds
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/14/2010WO2010116270A1 Ep2/4 agonists
10/14/2010WO2010115641A1 Process for the synthesis of chiral cyclic carbamates
10/14/2010WO2010115640A1 Process for the synthesis of cyclic carbamates
10/13/2010EP2239258A2 Tetrahydrobenzoxazine
10/13/2010CN101857548A Two-aromatic amino terminated dianthracene compound, preparation method and application thereof
10/12/2010US7812023 Methods of using substituted morpholine derivatives
10/12/2010US7812017 such as 1-(Phenylsulfonyl)-4-(piperazin-1-ylmethyl)-1H- indole, hydrochloride, used as dietetics, selective serotonin receptor antagonists or in cosmetics
10/12/2010CA2478283C Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
10/07/2010US20100256382 Tri-aryl compounds and compositions comprising the same
10/07/2010US20100256367 Pharmaceutical Composition For Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyactylate Derivatives
10/07/2010US20100256363 SYNTHESIS OF INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE TYPE 1
10/07/2010US20100256362 Method of producing benzoxazinone-based compound
10/07/2010US20100256150 Cyclic hydroxylamine as psychoactive compounds
10/07/2010US20100256131 Carbonyl compounds
10/07/2010US20100256130 Morpholinyl and pyrrolidinyl analogs
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256096 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
10/07/2010US20100256082 Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties
10/06/2010EP2234993A1 Bis- (sulf onylamino) derivatives for use in therapy
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807670 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth
10/05/2010US7807669 Peroxisome proliferator-activated receptor type gamma (PPAR- gamma) modulators such as (S)-3-{3'-[(benzoylmethylamino)methyl]biphenyl-4-yl}-2-(1-methyl-3-oxo-3-phenylpropenylamino)propionic acid, suited for use in dermatology, immunology, cardiovascular diseases and/or hyperlipemia
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 112